Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 4/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17469432 | 1.00 | TSHR (0.37) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL2614953 | 1.00 | TSHR (0.37) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL2544991 | 0.87 | — | — | |
| SCHEMBL55045 | 0.87 | — | — | |
| SCHEMBL53570 | 0.87 | — | — | |
| SCHEMBL14196343 | 0.85 | TSHR (0.39) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL12806454 | 0.85 | MMP1 (0.48) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL25649638 | 0.85 | ALDH1A1 (0.42) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL28902938 | 0.84 | — | — | |
| Methyl Alcohol SCHEMBL27770158 | 0.84 | TSHR (0.46) | TSHRHSD17B10MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170196826-A1 | Oligomeric forms of 3-hydroxybutyrate | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2017-07-13 | — | — | US | disclosed |
| US-20170196826-A1 | Oligomeric forms of 3-hydroxybutyrate | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2017-07-13 | — | — | US | disclosed |
| WO-2016012657-A1 | OLIGOMERIC FORMS OF 3-HYDROXYBUTYRATE | OULUN YLIOPISTO (FI) | 2016-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170196826-A1 | Oligomeric forms of 3-hydroxybutyrate | HADHB, ABAT, BCL2 | TSHR 4397/4885HSD17B10 52/4885MGAM 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.